Literature DB >> 28366204

RIPK3 Restricts Viral Pathogenesis via Cell Death-Independent Neuroinflammation.

Brian P Daniels1, Annelise G Snyder1, Tayla M Olsen1, Susana Orozco2, Thomas H Oguin3, Stephen W G Tait4, Jennifer Martinez3, Michael Gale5, Yueh-Ming Loo6, Andrew Oberst7.   

Abstract

Receptor-interacting protein kinase-3 (RIPK3) is an activator of necroptotic cell death, but recent work has implicated additional roles for RIPK3 in inflammatory signaling independent of cell death. However, while necroptosis has been shown to contribute to antiviral immunity, death-independent roles for RIPK3 in host defense have not been demonstrated. Using a mouse model of West Nile virus (WNV) encephalitis, we show that RIPK3 restricts WNV pathogenesis independently of cell death. Ripk3-/- mice exhibited enhanced mortality compared to wild-type (WT) controls, while mice lacking the necroptotic effector MLKL, or both MLKL and caspase-8, were unaffected. The enhanced susceptibility of Ripk3-/- mice arose from suppressed neuronal chemokine expression and decreased central nervous system (CNS) recruitment of T lymphocytes and inflammatory myeloid cells, while peripheral immunity remained intact. These data identify pleiotropic functions for RIPK3 in the restriction of viral pathogenesis and implicate RIPK3 as a key coordinator of immune responses within the CNS.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  RIPK1; RIPK3; West Nile virus; chemokines; necroptosis; neuroimmunology; neuroinflammation

Mesh:

Substances:

Year:  2017        PMID: 28366204      PMCID: PMC5405738          DOI: 10.1016/j.cell.2017.03.011

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  67 in total

1.  RIPK3 Activates Parallel Pathways of MLKL-Driven Necroptosis and FADD-Mediated Apoptosis to Protect against Influenza A Virus.

Authors:  Shoko Nogusa; Roshan J Thapa; Christopher P Dillon; Swantje Liedmann; Thomas H Oguin; Justin P Ingram; Diego A Rodriguez; Rachelle Kosoff; Shalini Sharma; Oliver Sturm; Katherine Verbist; Peter J Gough; John Bertin; Boris M Hartmann; Stuart C Sealfon; William J Kaiser; Edward S Mocarski; Carolina B López; Paul G Thomas; Andrew Oberst; Douglas R Green; Siddharth Balachandran
Journal:  Cell Host Microbe       Date:  2016-06-16       Impact factor: 21.023

2.  RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS.

Authors:  Yasushi Ito; Dimitry Ofengeim; Ayaz Najafov; Sudeshna Das; Shahram Saberi; Ying Li; Junichi Hitomi; Hong Zhu; Hongbo Chen; Lior Mayo; Jiefei Geng; Palak Amin; Judy Park DeWitt; Adnan Kasim Mookhtiar; Marcus Florez; Amanda Tomie Ouchida; Jian-bing Fan; Manolis Pasparakis; Michelle A Kelliher; John Ravits; Junying Yuan
Journal:  Science       Date:  2016-08-05       Impact factor: 47.728

3.  Propagation, quantification, detection, and storage of West Nile virus.

Authors:  James D Brien; Helen M Lazear; Michael S Diamond
Journal:  Curr Protoc Microbiol       Date:  2013-11-05

4.  Kinase RIP3 is dispensable for normal NF-kappa Bs, signaling by the B-cell and T-cell receptors, tumor necrosis factor receptor 1, and Toll-like receptors 2 and 4.

Authors:  Kim Newton; Xiaoqing Sun; Vishva M Dixit
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

5.  Cutting Edge: RIP1 kinase activity is dispensable for normal development but is a key regulator of inflammation in SHARPIN-deficient mice.

Authors:  Scott B Berger; Viera Kasparcova; Sandy Hoffman; Barb Swift; Lauren Dare; Michelle Schaeffer; Carol Capriotti; Michael Cook; Joshua Finger; Angela Hughes-Earle; Philip A Harris; William J Kaiser; Edward S Mocarski; John Bertin; Peter J Gough
Journal:  J Immunol       Date:  2014-05-12       Impact factor: 5.422

6.  Inflammasome adaptor protein Apoptosis-associated speck-like protein containing CARD (ASC) is critical for the immune response and survival in west Nile virus encephalitis.

Authors:  Mukesh Kumar; Kelsey Roe; Beverly Orillo; Daniel A Muruve; Vivek R Nerurkar; Michael Gale; Saguna Verma
Journal:  J Virol       Date:  2013-01-09       Impact factor: 5.103

7.  Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation.

Authors:  Young Sik Cho; Sreerupa Challa; David Moquin; Ryan Genga; Tathagat Dutta Ray; Melissa Guildford; Francis Ka-Ming Chan
Journal:  Cell       Date:  2009-06-12       Impact factor: 41.582

8.  Genetic diversity in the collaborative cross model recapitulates human West Nile virus disease outcomes.

Authors:  Jessica B Graham; Sunil Thomas; Jessica Swarts; Aimee A McMillan; Martin T Ferris; Mehul S Suthar; Piper M Treuting; Renee Ireton; Michael Gale; Jennifer M Lund
Journal:  MBio       Date:  2015-05-05       Impact factor: 7.867

9.  RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKL.

Authors:  Kate E Lawlor; Nufail Khan; Alison Mildenhall; Motti Gerlic; Ben A Croker; Akshay A D'Cruz; Cathrine Hall; Sukhdeep Kaur Spall; Holly Anderton; Seth L Masters; Maryam Rashidi; Ian P Wicks; Warren S Alexander; Yasuhiro Mitsuuchi; Christopher A Benetatos; Stephen M Condon; W Wei-Lynn Wong; John Silke; David L Vaux; James E Vince
Journal:  Nat Commun       Date:  2015-02-18       Impact factor: 14.919

10.  Viral pathogen-associated molecular patterns regulate blood-brain barrier integrity via competing innate cytokine signals.

Authors:  Brian P Daniels; David W Holman; Lillian Cruz-Orengo; Harsha Jujjavarapu; Douglas M Durrant; Robyn S Klein
Journal:  MBio       Date:  2014-08-26       Impact factor: 7.867

View more
  67 in total

1.  Intratumoral activation of the necroptotic pathway components RIPK1 and RIPK3 potentiates antitumor immunity.

Authors:  Annelise G Snyder; Nicholas W Hubbard; Michelle N Messmer; Sigal B Kofman; Cassidy E Hagan; Susana L Orozco; Kristy Chiang; Brian P Daniels; David Baker; Andrew Oberst
Journal:  Sci Immunol       Date:  2019-06-21

Review 2.  Programmed Cell Death and Inflammation: Winter Is Coming.

Authors:  Joseph P Kolb; Thomas H Oguin; Andrew Oberst; Jennifer Martinez
Journal:  Trends Immunol       Date:  2017-07-19       Impact factor: 16.687

3.  RIPped for neuroinflammation.

Authors:  Bart Tummers; Douglas R Green
Journal:  Cell Res       Date:  2017-05-19       Impact factor: 25.617

4.  RIPK3 Activation Leads to Cytokine Synthesis that Continues after Loss of Cell Membrane Integrity.

Authors:  Susana L Orozco; Brian P Daniels; Nader Yatim; Michelle N Messmer; Giovanni Quarato; Haiyin Chen-Harris; Sean P Cullen; Annelise G Snyder; Pooja Ralli-Jain; Sharon Frase; Stephen W G Tait; Douglas R Green; Matthew L Albert; Andrew Oberst
Journal:  Cell Rep       Date:  2019-08-27       Impact factor: 9.423

5.  Necroptosis, the Other Main Caspase-Independent Cell Death.

Authors:  Larissa C Zanetti; Ricardo Weinlich
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  Outcomes of RIP Kinase Signaling During Neuroinvasive Viral Infection.

Authors:  Brian P Daniels; Andrew Oberst
Journal:  Curr Top Microbiol Immunol       Date:  2020-04-07       Impact factor: 4.291

Review 7.  Benefits and Perils of Necroptosis in Influenza Virus Infection.

Authors:  Siddharth Balachandran; Glenn F Rall
Journal:  J Virol       Date:  2020-04-16       Impact factor: 5.103

8.  Caspase-8 restricts antiviral CD8 T cell hyperaccumulation.

Authors:  Yanjun Feng; Lisa P Daley-Bauer; Linda Roback; Hongyan Guo; Heather S Koehler; Marc Potempa; Lewis L Lanier; Edward S Mocarski
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-08       Impact factor: 11.205

9.  The Nucleotide Sensor ZBP1 and Kinase RIPK3 Induce the Enzyme IRG1 to Promote an Antiviral Metabolic State in Neurons.

Authors:  Brian P Daniels; Sigal B Kofman; Julian R Smith; Geoffrey T Norris; Annelise G Snyder; Joseph P Kolb; Xia Gao; Jason W Locasale; Jennifer Martinez; Michael Gale; Yueh-Ming Loo; Andrew Oberst
Journal:  Immunity       Date:  2019-01-08       Impact factor: 31.745

10.  Intracellular Nucleic Acid Sensing Triggers Necroptosis through Synergistic Type I IFN and TNF Signaling.

Authors:  Michelle Brault; Tayla M Olsen; Jennifer Martinez; Daniel B Stetson; Andrew Oberst
Journal:  J Immunol       Date:  2018-03-14       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.